sulfonamides and trimethoprim

24
SULFONAMIDES AND TRIMETHOPRIM 1 Abhinav Sawhney M. Pharmacy (Pharmacology) A10654913001 Amity Institute of Pharmacy Amity University NOIDA

Upload: abhinav-sawhney

Post on 18-Dec-2014

194 views

Category:

Health & Medicine


5 download

DESCRIPTION

 

TRANSCRIPT

Page 1: Sulfonamides and trimethoprim

1

SULFONAMIDES AND TRIMETHOPRIM

Abhinav SawhneyM. Pharmacy (Pharmacology)

A10654913001Amity Institute of Pharmacy

Amity University NOIDA

Page 2: Sulfonamides and trimethoprim

2

Antifolate drugs

Sulfonamides Trimethoprim Trimethoprim & Sulfamethoxazole

mixture

Page 3: Sulfonamides and trimethoprim

Discovery of Sulfonamides

The discovery of sulfonamides is a significant milestone event in the human chemotherapeutic history. Sulfonamides are synthetic compounds that have activity against both gram-positive and gram- negative bacteria.

Originally, sulfonamides were synthesized in Germany as azodyes. In an attempt to expand on earlier ideas of using dyes as antimicrobial agents, a man by the name of Domagk

Page 4: Sulfonamides and trimethoprim

Basic Structure

Page 5: Sulfonamides and trimethoprim

5

Sulfonamides: chemistry

Page 6: Sulfonamides and trimethoprim

Mechanism of Action (Wood-fields Theory)

Fol i c ai cd Di hydrofol i c aci d Tetrahydrofol i c aci d

Coezyme F

Fol ate Raductase Di hydrofol ate Raductase

The bi osynthesi s of DNA/ RNA

The structure of folic acid

N

N

N

N

Pteridine

H2N

O

HN

HN

OCOOH

COOH

PABA Glutamic acid

Folic acid

Page 7: Sulfonamides and trimethoprim

HN

N N

N

H2N

O

O P

O

OH

O P

OOH

OH

H

HN2

COOH

PABADihydropteroate synthaseHN

N N

N

H2N

O

NH

COOH

Dihdropteroic acid

HN

N N

N

H2N

O

NH

CONHCHCH2CH2COOH

COOH

H

Glutamic acid

Dihydrofolic acid (DHFA)

H2N

SO2NH2

HN

N N

N

H2N

O

NH

SO2NH2

H False Dihdropteroic acid

HN

N N

N

H2N

O

NH

CONHCHCH2CH2COOH

COOH

H

H

Tetrahydrofolic acid (THFA)

Dihydrofolate Reductase (DHFR)

TMP

Page 8: Sulfonamides and trimethoprim

8

Sulfonamides: antimicrobial activity

Gram positive and negative bacteria Nocardia, chlamydia trachomatis Some protoza Some enteric bacteria

Page 9: Sulfonamides and trimethoprim

9

Sulfonamides: resistance

Overproduction of PABA Low affinity dihydropteroate synthase Loss of permeability to sulfonamides

Page 10: Sulfonamides and trimethoprim

10

Sulfonamides: pharmacokinetics

Oral absorbable Short Medium Long

Oral, nonabsorbable

Serum protein bind 20 ~ 90%

Excreted into urine

Page 11: Sulfonamides and trimethoprim

11

Pharmacokinetic Properties of Some Sulfonamides and Trimethoprim

Drug Half-Life Oral Absorption

Sulfonamides

Sulfacytine Short Prompt (peak levels in 1–4 hours)

Sulfisoxazole Short (6 hours) Prompt

Sulfamethizole Short (9 hours) Prompt

Sulfadiazine Intermediate (10–17 hours) Slow (peak levels in 4–8 hours)

Sulfamethoxazole Intermediate (10–12 hours) Slow

Sulfapyridine Intermediate (17 hours) Slow

Sulfadoxine Long (7–9 days) Intermediate

Pyrimidines

Trimethoprim Intermediate (11 hours) Prompt

Page 12: Sulfonamides and trimethoprim

12

Sulfonamides: clinical uses

Oral absorbable agents Sulfamethoxazole (GANTANLOL 0.5gm tab.)

To treat urinary tract infection Sulfadiazine (0.5 gm QID): toxoplasmosis Sulfadoxine: long acting, in a combination for treatment

of malaria Oral nonabsorbable agents

Ulcerative colitis, enteritis, other inflammatory bowel disease

Topical agents Sulfacetamide (LOCULA 10% eye drops.): ophthalemic Mafenide (SULFAMYLON 1% cream): topical Silver sulfadiazine ( SILVIRIN 15% cream): topically

Page 13: Sulfonamides and trimethoprim

13

Sulfonamides: adverse reactions

Cross allergenic sulfonamide drugs: Thiazide, furosemide, diazoxide, sulfonylurea

hypoglycemic agents, and others Fever, skin rashes, exfoliative

dermatitis,photosensivity, urticaria, nausea, vomiting, diarrhoea

Stevens-Johnson syndrom Urinary tract disturbances

Crystalluria, hemturia Hematopoietic disturbance

Hemolytic or aplastic anemia Granulocytopenia, thrombocytopenia, leukmoid

reaction Hemolysis in G-6PDH deficient patients Kernicterus in newborn of mothers have taken near

the end of pergnancy

Page 14: Sulfonamides and trimethoprim

14

Trimethoprim: chemistry

Page 15: Sulfonamides and trimethoprim

15

Trimethoprim: resistance

Reduced cell permeability Overproduction of DHF reductase Altered affinity of reductase

Page 16: Sulfonamides and trimethoprim

16

Trimethoprim: pharmacokinetics

Usually given orally alone or in combination with sulfamethoxazole

Mainly excreted into urine

Page 17: Sulfonamides and trimethoprim

17

Clinical use Oral trimethoprim

Acute urinary infection Oral trimethoprim-sulfamethoxazole

Pjiroveci pneumonia, shigellosis, systemic salmonella infection, complicated urinary tract infection,

Active against many respiratory pathogens Intravenous trimethoprim-sulfamethoxazole

Gram negative sepsis, pneumocystis pneumonia Shigllosis, typhoid fever

Oral pryrimethamine with sulfanamide With sulfadiazine in Leishmaniasis, toxoplasmosis With sulfadoxine in malaria

Page 18: Sulfonamides and trimethoprim

18

Adverse effects

Megaloblastic anemia Leukopenia, granulocytopenia Can be prevented by folinic acid The AIDS patients have high frequency of

unwanted reactions

Page 19: Sulfonamides and trimethoprim

COTRIMOXAZOLE

Optimal ratio of the two drugs is 5:1 sulfa :trimethoprim.

Septran, Sepmax, Bactrim, Ciplin

80mg + 400mg tab: 2 BD for 2 days

160mg + 800mg tab (DS): 1 BD

Page 20: Sulfonamides and trimethoprim

Synergism

Page 21: Sulfonamides and trimethoprim

ADVANTAGES

Expanded number of organisms inhibited.

Bactericidal .

Decreased resistance.

Decreased toxicity.

Page 22: Sulfonamides and trimethoprim

22

BRANDS AVAILABLE IN MARKET

SILVEZ ( silver sulfadiazine 1% w/w ) Topical used, Laborate

ALBUCID(Sulphacetamide 10% ointment, 10-30% eye drop ) opthalmic , Allergan

AUBRIL ( Sulphadiazine 410 mg + Trimethoprim 90 mg) Tablet, Novartis Pharma

AMALAR ( Sulfadoxine 500 mg + Pyrimethamine 25 mg) tablet, Micro

SEPTRAN ( Sulfamethoxazole + Trimethoprim 80 mg) tablet, GSK

Page 23: Sulfonamides and trimethoprim

23

REFERENCE

Rang H.P; Dale M.M; etal “ Rang and Dale’s Pharmacology, 7th edition, p.no 622-625

Tripathi K.D. “Essentials of Molecular Pharmacology” 6th Edn. P.no 682-687

Goodman & Gillman, “ The Pharmacological Basis of Therapeutics”, 12th edn

Page 24: Sulfonamides and trimethoprim

24